Top Tweets for #abc07

Helen Morement @HelenMorement

about 2 years ago

Prof Maria Hawkins presented the outcome of #ABC07 at #ASCO24 today. No PFS benefit from adding #SBRT to #CisGem in #iCCA/#hCCA, but SBRT well tolerated & didn’t increase biliary infections, plus fewer liver failure deaths in SBRT cohort. #cholangiocarcinoma #livertwitter #ammf

HelenMorement's tweet photo. Prof Maria Hawkins presented the outcome of #ABC07 at #ASCO24 today. No PFS benefit from adding #SBRT to #CisGem in #iCCA/#hCCA, but SBRT well tolerated & didn’t increase biliary infections, plus fewer liver failure deaths in SBRT cohort. #cholangiocarcinoma #livertwitter #ammf https://t.co/GBkSU56L51

HelenMorement's tweet photo. Prof Maria Hawkins presented the outcome of #ABC07 at #ASCO24 today. No PFS benefit from adding #SBRT to #CisGem in #iCCA/#hCCA, but SBRT well tolerated & didn’t increase biliary infections, plus fewer liver failure deaths in SBRT cohort. #cholangiocarcinoma #livertwitter #ammf https://t.co/GBkSU56L51

HelenMorement's tweet photo. Prof Maria Hawkins presented the outcome of #ABC07 at #ASCO24 today. No PFS benefit from adding #SBRT to #CisGem in #iCCA/#hCCA, but SBRT well tolerated & didn’t increase biliary infections, plus fewer liver failure deaths in SBRT cohort. #cholangiocarcinoma #livertwitter #ammf https://t.co/GBkSU56L51

HelenMorement's tweet photo. Prof Maria Hawkins presented the outcome of #ABC07 at #ASCO24 today. No PFS benefit from adding #SBRT to #CisGem in #iCCA/#hCCA, but SBRT well tolerated & didn’t increase biliary infections, plus fewer liver failure deaths in SBRT cohort. #cholangiocarcinoma #livertwitter #ammf https://t.co/GBkSU56L51

1

10

2

0

433

Angela Lamarca @DrAngelaLamarca

about 2 years ago

#ABC07 trial at #ASCO24 NO benefit from adding #SBRT to #CisGem in #iCCA/#hCCA 😕Similar PFS 😕Similar OS 👍Less liver tox in SBRT Still, for sure locoregional therapies have a role! 😊 Lets keep re-searching��🏻‍♀️🔍👀 @myESMO @_SEOM @GrupoTTD @atuvibi @CharityAMMF @curecc

DrAngelaLamarca's tweet photo. #ABC07 trial at #ASCO24

NO benefit from adding #SBRT to #CisGem in #iCCA/#hCCA

😕Similar PFS
😕Similar OS

👍Less liver tox in SBRT

Still, for sure locoregional therapies have a role! 😊
Lets keep re-searching��🏻‍♀️🔍👀

@myESMO @_SEOM @GrupoTTD @atuvibi @CharityAMMF @curecc https://t.co/AvbGFN87Nr

DrAngelaLamarca's tweet photo. #ABC07 trial at #ASCO24

NO benefit from adding #SBRT to #CisGem in #iCCA/#hCCA

😕Similar PFS
😕Similar OS

👍Less liver tox in SBRT

Still, for sure locoregional therapies have a role! 😊
Lets keep re-searching��🏻‍♀️🔍👀

@myESMO @_SEOM @GrupoTTD @atuvibi @CharityAMMF @curecc https://t.co/AvbGFN87Nr

DrAngelaLamarca's tweet photo. #ABC07 trial at #ASCO24

NO benefit from adding #SBRT to #CisGem in #iCCA/#hCCA

😕Similar PFS
😕Similar OS

👍Less liver tox in SBRT

Still, for sure locoregional therapies have a role! 😊
Lets keep re-searching��🏻‍♀️🔍👀

@myESMO @_SEOM @GrupoTTD @atuvibi @CharityAMMF @curecc https://t.co/AvbGFN87Nr

DrAngelaLamarca's tweet photo. #ABC07 trial at #ASCO24

NO benefit from adding #SBRT to #CisGem in #iCCA/#hCCA

😕Similar PFS
😕Similar OS

👍Less liver tox in SBRT

Still, for sure locoregional therapies have a role! 😊
Lets keep re-searching��🏻‍♀️🔍👀

@myESMO @_SEOM @GrupoTTD @atuvibi @CharityAMMF @curecc https://t.co/AvbGFN87Nr

0

36

17

2

2K

RTTQA @RTTQA_UK

over 2 years ago

@dathdd presents some of the results from the #RTQA for #ABC07 @SABRconsortium - use of benchmarking helped improve on-trial protocol compliance #uksabr23

RTTQA_UK's tweet photo. @dathdd presents some of the results from the #RTQA for #ABC07 @SABRconsortium - use of benchmarking helped improve on-trial protocol compliance
#uksabr23 https://t.co/uqFkbm7RPJ

0

6

1

0

421

Last Seen Hashtags on Sotwe

Trends for you

Most Popular Users